| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $201.7M | +3.4% | +15.2% |
| Cost of Revenue | $92.9M | +2.5% | +8.0% |
| Gross Profit | $108.8M | +4.1% | +22.2% |
| R&D Expense | $38.9M | +5.5% | +5.5% |
| SG&A Expense | $31.7M | +2.2% | +0.7% |
| Operating Income | $11.0M | +11.8% | +186.0% |
| Pre-tax Income | $15.2M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $472.4M | +14.0% | +47.5% |
| Short-term Investments | $96.3M | -18.2% | +10.0% |
| Accounts Receivable | $69.9M | +15.8% | +20.6% |
| Current Assets | $707.3M | +7.2% | +34.4% |
| Total Assets | $1.43B | +3.0% | +12.1% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $137.8M | — | — |
| Capital Expenditures | $4.8M | — | — |
| Investing Cash Flow | -$28.3M | — | — |
| Financing Cash Flow | $4.2M | — | — |
| Free Cash Flow | $133.0M | — | — |
| +12.7% |
| +259.5% |
| Income Tax | $160K | -90.8% | -92.9% |
| Net Income | $15.0M | +27.9% | +227.6% |
| EPS (Basic) | $0.24 | +26.3% | +220.0% |
| EPS (Diluted) | $0.23 | +27.8% | +215.0% |
| $731.6M |
| -0.1% |
| +247.1% |
| Total Liabilities | $803.8M | +0.3% | +3.4% |
| Stockholders' Equity | $622.9M | +6.6% | +25.8% |